NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 981 filers reported holding NOVARTIS A G in Q2 2018. The put-call ratio across all filers is 0.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $4,491,000 | -27.1% | 55,545 | -24.3% | 1.41% | -22.5% |
Q4 2017 | $6,160,000 | -2.2% | 73,370 | -0.0% | 1.82% | -6.7% |
Q3 2017 | $6,300,000 | +3.3% | 73,385 | +0.4% | 1.96% | +9.2% |
Q2 2017 | $6,100,000 | +136.9% | 73,080 | +110.8% | 1.79% | +104.9% |
Q1 2017 | $2,575,000 | +3.1% | 34,670 | +1.1% | 0.87% | +2.7% |
Q4 2016 | $2,498,000 | -8.5% | 34,290 | -0.8% | 0.85% | -10.3% |
Q3 2016 | $2,729,000 | -11.8% | 34,565 | -7.8% | 0.95% | -14.0% |
Q2 2016 | $3,094,000 | -14.8% | 37,500 | -4.3% | 1.10% | -15.8% |
Q4 2014 | $3,632,000 | -18.5% | 39,199 | -17.3% | 1.31% | -21.4% |
Q3 2014 | $4,459,000 | -4.5% | 47,374 | -8.1% | 1.67% | -1.9% |
Q2 2014 | $4,667,000 | +3.9% | 51,555 | -2.5% | 1.70% | +0.6% |
Q1 2014 | $4,493,000 | +1.1% | 52,850 | -4.4% | 1.69% | +4.2% |
Q4 2013 | $4,444,000 | -23.0% | 55,285 | -26.5% | 1.62% | -26.8% |
Q3 2013 | $5,772,000 | +7.8% | 75,245 | -0.6% | 2.21% | +3.0% |
Q2 2013 | $5,353,000 | – | 75,706 | – | 2.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |